Screener
GeneDx Holdings WGS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Total non-operating expense, net | (4,948) | (1,531) |
| Loss before income taxes | (62,419) | (6,082) |
| Income tax expense | (897) | (447) |
| Net loss | $(63,316) | $(6,529) |
| Other comprehensive (loss) income, net of tax | ||
| Unrealized (loss) gain related to available for sale securities, net | (253) | 75 |
| Comprehensive loss | $(63,569) | $(6,454) |
| Weighted-average shares outstanding of Class A common stock | 29,335,126 | 28,147,948 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's net income?
- GeneDx Holdings (WGS) reported net income of -$63.32M in Q1 2026.
- How has GeneDx Holdings's net income changed year-over-year?
- GeneDx Holdings's net income decreased by 869.8% year-over-year, from -$6.53M to -$63.32M.
- What is the long-term trend for GeneDx Holdings's net income?
- Over 3 years (2021 to 2025), GeneDx Holdings's net income has grown at a -55.9% compound annual growth rate (CAGR), from -$245.39M to -$21.02M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about GeneDx Holdings's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude